W. Cliff Rutter
- Pharmacology top 5%
- Infectious Diseases top 10%
- Epidemiology
- Nephrology top 5%
- Molecular Medicine top 5%
- Co-authors
- David S. BurgessDonna R. BurgessCraig A. MartinJeffery TalbertRyan L. CrassRonald G. HallGrace C. LeeDavid J. Feola
- Topics
- Antibiotics Pharmacokinetics and Efficacy (17 papers)Antimicrobial Resistance in Staphylococcus (8 papers)Acute Kidney Injury Research (6 papers)
- Journals
- The LancetBloodAnnals of Surgery
- Partner nations
- United States
In The Last Decade
W. Cliff Rutter
21 papers receiving 395 citations
Peers
Comparison fields: 5 of 62
- Pharmacology 255
- Infectious Diseases 144
- Epidemiology 126
- Nephrology 115
- Molecular Medicine 90
Countries citing papers authored by W. Cliff Rutter
This map shows the geographic impact of W. Cliff Rutter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Cliff Rutter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Cliff Rutter more than expected).
Fields of papers citing papers by W. Cliff Rutter
This network shows the impact of papers produced by W. Cliff Rutter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Cliff Rutter. The network helps show where W. Cliff Rutter may publish in the future.
Co-authorship network of co-authors of W. Cliff Rutter
This figure shows the co-authorship network connecting the top 25 collaborators of W. Cliff Rutter. A scholar is included among the top collaborators of W. Cliff Rutter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Cliff Rutter. W. Cliff Rutter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 11 | |
| 3 | 20 | |
| 4 | 50 | |
| 5 | 53 | |
| 6 | 33 | |
| 7 | 28 | |
| 8 | 21 | |
| 9 | 0 | |
| 10 | 48 | |
| 11 | 11 | |
| 12 | 1 | |
| 13 | 1 | |
| 14 | 94 | |
| 15 | 3 | |
| 16 | 0 | |
| 17 | 1 | |
| 18 | 1 | |
| 19 | 1 | |
| 20 | 6 |
About W. Cliff Rutter
W. Cliff Rutter is a scholar working on Pharmacology, Molecular Medicine and Toxicology, having authored 24 papers that have together received 402 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Antimicrobial Resistance in Staphylococcus (8 papers) and Acute Kidney Injury Research (6 papers). The work is most often cited by research in Molecular Medicine (90 citations), Nephrology (115 citations) and Pharmacology (255 citations). W. Cliff Rutter has collaborated with scholars based in United States. Frequent co-authors include David S. Burgess, Donna R. Burgess, Craig A. Martin, Jeffery Talbert, Ryan L. Crass, Ronald G. Hall, Grace C. Lee, David J. Feola, Andrew Redd and Jud C. Janak. Their work appears in journals such as The Lancet, Blood and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.